TW200512209A - Treating and/or preventing agent for pulmonary diseases - Google Patents
Treating and/or preventing agent for pulmonary diseasesInfo
- Publication number
- TW200512209A TW200512209A TW093108843A TW93108843A TW200512209A TW 200512209 A TW200512209 A TW 200512209A TW 093108843 A TW093108843 A TW 093108843A TW 93108843 A TW93108843 A TW 93108843A TW 200512209 A TW200512209 A TW 200512209A
- Authority
- TW
- Taiwan
- Prior art keywords
- treating
- preventing agent
- pulmonary diseases
- pulmonary
- chronic
- Prior art date
Links
- 208000019693 Lung disease Diseases 0.000 title abstract 2
- 206010069351 acute lung injury Diseases 0.000 abstract 2
- 230000001684 chronic effect Effects 0.000 abstract 2
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 206010014561 Emphysema Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 201000009240 nasopharyngitis Diseases 0.000 abstract 1
- 230000003448 neutrophilic effect Effects 0.000 abstract 1
- 230000000414 obstructive effect Effects 0.000 abstract 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 abstract 1
- 230000002685 pulmonary effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003094504 | 2003-03-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200512209A true TW200512209A (en) | 2005-04-01 |
Family
ID=33127392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW093108843A TW200512209A (en) | 2003-03-31 | 2004-03-31 | Treating and/or preventing agent for pulmonary diseases |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060205749A1 (zh) |
| EP (1) | EP1609471A1 (zh) |
| JP (1) | JPWO2004087148A1 (zh) |
| CN (1) | CN1767827A (zh) |
| CA (1) | CA2520686A1 (zh) |
| TW (1) | TW200512209A (zh) |
| WO (1) | WO2004087148A1 (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005056009A1 (ja) * | 2003-12-12 | 2005-06-23 | Kyowa Hakko Kogyo Co., Ltd. | 肺疾患治療剤 |
| US8088728B2 (en) * | 2005-06-24 | 2012-01-03 | Drugrecure Aps | Airway administration of tissue factor pathway inhibitor in inflammatory conditions affecting the respiratory tract |
| WO2020233713A1 (zh) * | 2019-05-22 | 2020-11-26 | 石药集团中奇制药技术（石家庄）有限公司 | 杂环化合物及其盐的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4042449A (en) * | 1975-07-24 | 1977-08-16 | The United States Of America As Represented By The Secretary Of The Navy | Method of making a reticle-lens |
| DE3523960A1 (de) * | 1985-07-04 | 1987-01-08 | Licentia Gmbh | Verfahren zur metallisierung eines elektrisch schlecht leitenden substrates aus einem anorganischen material |
| DE4125200A1 (de) * | 1991-07-30 | 1993-02-04 | Siemens Ag | Verfahren zur herstellung einer leuchtstoffschicht auf einem substrat |
| DE4230732C1 (zh) * | 1992-09-14 | 1993-09-09 | Schott Glaswerke, 55122 Mainz, De | |
| AU705690B2 (en) * | 1995-05-19 | 1999-05-27 | Kyowa Hakko Kogyo Co. Ltd. | Oxygen-containing heterocyclic compounds |
| WO2000050402A1 (en) * | 1999-02-25 | 2000-08-31 | Merck Frosst Canada & Co. | Pde iv inhibiting compounds, compositions and methods of treatment |
| DZ3019A1 (fr) * | 1999-03-01 | 2005-05-20 | Smithkline Beecham Corp | Utilisation d'un inhibiteur de pde4 dans la préparation d'un médicament contre la copd. |
| GB0113342D0 (en) * | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel Heterocycles 1 |
| TWI221838B (en) * | 2001-08-09 | 2004-10-11 | Tanabe Seiyaku Co | Pyrazinoisoquinoline compound or naphthalene compound |
| DE10205274A1 (de) * | 2002-02-08 | 2003-08-21 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen |
| JP4465429B2 (ja) * | 2002-02-21 | 2010-05-19 | 株式会社リコー | レーザ加工方法 |
| US6962940B2 (en) * | 2002-03-20 | 2005-11-08 | Celgene Corporation | (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| US20050245750A1 (en) * | 2002-07-03 | 2005-11-03 | Kyowa Hakko Kogyo Co., Ltd. | Process for preparing 1,3-benzodioxole-2-spirocycloalkane derivative |
-
2004
- 2004-03-31 EP EP04724790A patent/EP1609471A1/en not_active Withdrawn
- 2004-03-31 CN CNA2004800088568A patent/CN1767827A/zh active Pending
- 2004-03-31 TW TW093108843A patent/TW200512209A/zh unknown
- 2004-03-31 WO PCT/JP2004/004611 patent/WO2004087148A1/ja not_active Application Discontinuation
- 2004-03-31 CA CA002520686A patent/CA2520686A1/en not_active Abandoned
- 2004-03-31 JP JP2005504263A patent/JPWO2004087148A1/ja not_active Withdrawn
- 2004-03-31 US US10/550,030 patent/US20060205749A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20060205749A1 (en) | 2006-09-14 |
| CA2520686A1 (en) | 2004-10-14 |
| WO2004087148A1 (ja) | 2004-10-14 |
| EP1609471A1 (en) | 2005-12-28 |
| CN1767827A (zh) | 2006-05-03 |
| JPWO2004087148A1 (ja) | 2006-06-29 |
| WO2004087148A9 (ja) | 2005-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1326595E (pt) | Composicao farmaceutica compreendendo resveratrol para o tratamento de disturbios respiratorios inflamatorios | |
| NO2015024I2 (no) | glykopyrronium eller et salt derav | |
| IL167900A (en) | Use of betamimetics to prepare a medical preparation for the treatment of chronic obstructive pulmonary disease | |
| EA200702387A1 (ru) | Имидазохинолины в качестве ингибиторов липидкиназы | |
| TW200716648A (en) | Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia | |
| WO2011005811A8 (en) | Combination therapy for the treatment of diabetes | |
| EP1774968A4 (en) | BENZYLISOQUINOLEIN DERIVATIVE OR BISBENZYLISOQUINOLEIN DERIVATIVE - CONTAINING PSYCHOTROPIC, ANALGESIC AND / OR ANTIPHLOGISTIC AGENT, AND HEALTH FOOD. | |
| RU2007138270A (ru) | Комбинация антихолинергетиков и антагонистов лейкотриеновых рецепторов для лечения респираторных заболеваний и фармацевтическая композиция на ее основе | |
| WO2005075450A3 (en) | Spiro-benzodioxoles and their use as cb1 antagonists | |
| MXPA03010162A (es) | Un inhibidor de pde4 y un agente anticolinergico en combinacion para tratar enfermedades obstructivas de vias respiratorias. | |
| WO2007109118A3 (en) | RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS | |
| MXPA04005343A (es) | 4-fenil-tetrahidro-isoquinolinas sustituidas, procedimiento para su preparacion, su uso como medicamento, y medicamento que las contiene. | |
| PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
| BR0316458A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto | |
| MXPA03011702A (es) | Composicion que comprende un inhibidor de fosodiesterasa 4 y un antagonista de receptor h1 y el uso de los mismos para la elaboracion de un medicamento para el tratamiento de enfermedades respiratorias. | |
| HK1074582A1 (en) | Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd | |
| SE9900833D0 (sv) | Novel combination | |
| RS52944B (en) | ROFLUMILAST FOR TREATMENT OF PULMONARY HYPERTENSION | |
| EA200100906A1 (ru) | Композиция контролируемого высвобождения для лечения copd хронического обструктивного заболевания легких | |
| TW200512209A (en) | Treating and/or preventing agent for pulmonary diseases | |
| EP1627873A4 (en) | BENZOFURAN-BASED COMPOUND AND MEDICINAL COMPOSITION CONTAINING THE SAME | |
| WO2005011602A3 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease | |
| NO20074661L (no) | Anvendelse av en forbindelse | |
| WO2003055880A3 (de) | Substituierte 4-phenyltetrahydroisochinolinium-salze, verfahren zu ihrer herstellung, ihrer verwendung als medikament, sowie sie enthaltendes medikament | |
| SE0201939D0 (sv) | New combination |